SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023615
Filing Date
2020-11-12
Accepted
2020-11-12 16:06:13
Documents
79
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20200930_10q.htm 10-Q 1168563
2 EXHIBIT 10.4 ex_212784.htm EX-10.4 169080
3 EXHIBIT 10.5 ex_212785.htm EX-10.5 20715
4 EXHIBIT 10.6 ex_212786.htm EX-10.6 23475
5 EXHIBIT 31.1 ex_201803.htm EX-31.1 16910
6 EXHIBIT 32.1 ex_201804.htm EX-32.1 9692
13 pipelineqthree.jpg GRAPHIC 101811
  Complete submission text file 0001437749-20-023615.txt   6238998

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vxrt-20200930.xml EX-101.INS 1082999
8 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20200930.xsd EX-101.SCH 69929
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20200930_cal.xml EX-101.CAL 46129
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20200930_def.xml EX-101.DEF 449261
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20200930_lab.xml EX-101.LAB 389464
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20200930_pre.xml EX-101.PRE 477272
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 201306623
SIC: 2836 Biological Products, (No Diagnostic Substances)